SMTL have moved ....
... to a new laboratory in the Princess of Wales Hospital.
The Surgical Materials Testing Laboratory has completed its move to
new premises at the Princess of Wales Hospital in Bridgend.
We would like to take this opportunity of formally thanking everyone
in the Bridgend and District NHS Trust who helped
make the move possible, especially Paul
Stauber and Sian Morgan.
We now have a range of excellent laboratory facilities, including
-
A chemical laboratory, where we are currently working
on test methods to measure the rate of chemical permeation (such
as cytotoxic drugs) through
gloves.
-
A controlled environment laboratory (CEL), where the temperature
and humidity are maintained at constant levels.
In this lab we carry out testing of elastic products (e.g., gloves,
bandages, stockings) and any tests requiring the use of the Instron
tensiometer.
-
A cell culture laboratory, where toxicity testing of medical devices
is performed, including the tests
used to ensure that catheters purchased on the new
All Wales urology contract were free of toxic residues, and therefore
would not cause urethral stricture.
-
A physical testing laboratory, for tests which
do not require the special conditions of the CEL.
The equipment in this laboratory was used recently to produce
evidence for an inquest into the death of a patient due to
defective renal catheter equipment.
-
A microbiological laboratory, where sterility testing and endotoxin
testing is performed.
This same lab also houses the equipment used to determine the levels
of protein in gloves, which is vital to ensure that NHS staff in Wales
do not develop latex allergies.
-
A "Wets" laboratory -- so called because it is used to test gloves and
sharps bins for leakage, and failure of these products can result
in copious amounts of water flooding over the floor!
-
The Biosurgery Research Unit - a suite of 4 laboratories where flies
and their larvae are cultured for use in wound debridement.
(See later in the newsletter for more on the success of our larvae).
-
As well as offices and store-rooms for samples, the upstairs includes a
small seminar room, which can seat up to 12 people, and is frequently
used for pre-adjudication meetings with Welsh Health Supplies.
If you are in Bridgend and would like to see the laboratory, please
contact us to arrange a visit.
Maggots - The New Millennium Bug
In November, Peter Mandelson announced that
The Biosurgical Research Unit (part of SMTL and the only centre to
produce
sterile maggots in the United Kingdom) had been granted Millennium
Product status by the Design Council.
The maggots, sold under the brand name of LarvE, have been distributed
to over 350 centres in the United Kingdom and elsewhere in Europe.
Used to clean wounds that have leg ulcer pressure
sores and necrotic areas on the feet of diabetic patients, they have
been found to be remarkably effective.
Wounds that may require weeks or months of treatment with conventional
dressings can sometimes be cleaned with a single application of LarvE
over a three day period.
Since the announcement, the laboratory has received a lot of interest
from the media, including articles in the Independent, The Mirror,
The Evening Standard, Marketing and The Times, as well as coverage on
the BBC.
The Biosurgical Research Unit now has the right to apply the highly
prestigious ``Millennium Product Marque'' to the larval containers. It is
hoped that the larvae will be selected to be included in the
Millennium Dome when it's opened in Year 2000.
Dr Stephen Thomas
Pre-use inspection of disposables.
SMTL is the defect reporting centre for disposables for Wales. We
receive between 130 - 200 defect reports a year ranging from labelling
defects through to potentially life threatening defects.
Procedures for carrying out defect reporting are
documented in WHC(97)28 and subsequent amendments. Recently ECRI (an
American based organisation), recommended that pre-use
inspection of every medical disposable medical device was carried out
to reduce the impact of defective disposables on patient care. The
general procedures are included below.
Pre-use Inspection Procedure.
Consistently perform brief pre-use inspections, focusing both on the
packaging and the device. Typical steps include the following:-
-
Before opening the package conduct a visual through the package
inspection device for obvious defects where possible.
-
Check the packaging integrity. Are the package and seals intact?
If not, the sterility of the devise may be compromised and it should
not be used.
-
Verify the package label.
-
Is this the correct device for the patient and procedure ?
-
Does the label accurately identify the type and size of the device
contained in the package ?
-
If the device has an expiration date has
the date passed ?
-
Determine if there is any debris or unidentified material within
the package. This may be an indication that the integrity of the
packaging has been compromised and the device should not be used.
-
Check the label instructions to ensure proper usage.
Manufacturers
sometimes change the instructions, and the label may not necessarily
indicate that a change has occurred.
-
Determine whether the device is complete and properly assembled.
-
Verify all lumens are patent and balloons are intact.
-
Look for any external defects (eg. broken insulation of
electrodes, cracks or splits in catheters), check that all connections
and junctions are intact and secure, verify that all valves and ports
are properly oriented and functional.
What to do if a device is found to be defective.
Record the device name, model, batch number, expiry date of any
defective product. Save the device in its packaging if possible. If
possible obtain a number of unused sample from the same batch for
submission to SMTL for examination and testing.
Complete details
of this procedure should be found in WHC(97)28 appendix C, monographs
7 - 9. A form is also included in this circular from Welsh Office to
enable full reporting of the incident.
Please send the device and completed
forms to SMTL.
Peter Phillips
Purchasing non-CE marked devices.
Since the 14th June, all medical devices placed on the market must be
bear the CE mark. The only exceptions are allowed by the Commission
Decision 98/C 242/05, for those products already in the supply chain
(i.e., manufactured before this date and shipped to distributors etc).
However, certain products are still not CE marked,
either because the manufacturer has taken a decision not to CE mark
them (if, for example their European market is too small), or because
they are ignorant of the legislation (very few manufacturers are now
unaware of the Directive).
As it is now illegal to place on the market a medical device which
isn't CE marked, any manufacturer doing so is committing an
offence. It is not against the directive for someone to purchase a
non-CE marked device, but the medical device itself would be in breach
of the law. If an incident occurred, and subsequent investigation
found that the device involved did not comply with current legislation
(i.e., was not CE marked), the purchaser could be found to be liable.
Therefore, if an NHS Trust wishes to purchase a non-CE marked device,
they should take legal advice before purchasing the device as to the
potential implications for the Trust.
The Medical Devices Agency. should be informed of any medical devices
which are not CE marked.
Peter Phillips
SMTL success in the Journal of Wound Care awards.
Each year, the Journal of Wound Care in conjunction with Johnson & Johnson,
invite submissions for awards in three categories. These are
Research, a Literature Review, and Clinical Innovation. This year SMTL
was successful in winning first prize in the clinical innovation
section with a paper that describes a new technique of the management
of meningococcal skin lesions, the characteristic areas of reddish
blue discolouration most frequently found at the front or lower limbs
patients with this disease.
In severe cases these areas darken in colour and become necrotic
leading to extensive tissue loss that may involve muscle and bone. The
winning study described a case history in which a patient with such
lesions was treated with hydrogel and other modern dressings. As a
result of the treatment supplied, the patients wounds healed with minimal
scarring and no loss of movement. It is hoped that this approach
maybe considered in other situations in patients with this condition.
This submission also won a special award for the paper which made the
greatest contribution to patient care.
In addition the lab won a
second prize in the literature review category for a review of the
role of Compression Hosiery in the Prevention of Deep Vein Thrombosis.
This condition can develop resulting in formation of a fatal pulmonary
embolism or cause damage to the veins of the lower leg which result
in leg ulceration in later life. This history causes and diagnosis of
DVT were discussed as was the literature relating to the clinical
evidence for the use of various types of compression therapy.
Dr Stephen Thomas
Chlorinated gloves and Shelf Life.
Many users are confused over the effect chlorination has on medical
latex gloves, and whether it affects the shelf life.
Chlorination is an alternative to powdering medical gloves, so that
they can be donned.
Without powder, chlorination or some other coating, the gloves
are very difficult to put on as they are very "grippy".
As powder becomes less popular as a lubricant, many NHS staff are
turning to powder-free gloves, which are usually chlorinated.
The chlorination process is carried out by dipping the gloves in a
solution of chlorine for approximately 15 minutes.
A chemical reaction takes place, where the rubber polyisoprene
molecules cross-link with the chlorine to produce polychloroprene
(the
material that Neopreneis made of).
Thus a chlorinated latex glove can be thought of as being
``polychloroprene plated''.
Although the chlorine has an affect on the tensile strength (a
chlorinated gloves is usually less than 5% weaker than a
non-chlorinated glove), the shelf life is not reduced.
In fact, as the chlorinated surface is less receptive to oxygen, it
may well be that the gloves have a slightly better shelf life than
their non-chlorinated counterparts.
Peter Phillips
Personal Sharps Containers
Personal sharps containers, used in the community by drug
misusers
participating in needle exchange schemes,
have caused confusion in recent years.
Problems have been experienced in arranging All Wales contracts for
these devices as it has not been clear whether the containers complied with
current standards or legislation.
This article attempts to clarify some of these issues.
Personal sharps containers, used in the community by drug
misusers
participating in needle exchange schemes,
have caused confusion in recent years.
Problems have been experienced in arranging All Wales contracts for
these devices as it has not been clear whether the containers complied with
current standards or legislation.
This article attempts to clarify some of these issues.
Health and Safety Legislation.
In 1996, a piece of Health and Safety legislation was introduced into
the UK, the
"Carriage of Dangerous Goods" regulations, 1996.
These regulations stipulate the technical specifications for
containers containing clinical waste,
being transported by road or rail in a vehicle.
Containers which comply with the Act must carry the correct
designation (in the case of sharps containers
and other infected clinical waste containers is "Clinical waste,
unspecified, not otherwise stated" or "(Bio) Medical waste, not
otherwise stated" or "Regulated medical waste not otherwise stated"),
a UN number, a UN mark, and the correct danger sign (for sharps containers
this should be the "Infectious
substances" sign).
The ``UN number'' is a 4 digit number prefixed by ``UN''
and used as a means of identification for dangerous goods.
For example, UN 3291 correlates with "Clinical waste,
unspecified, not otherwise specified" etc.
The ``UN mark'' is a 14 character code, which
shows that the containers have been tested in
accordance with the requirements for packaging performance in the
United Nations
``Recommendations on the Transport of Dangerous Goods (9th revised
edition)''.
Whilst sharps containers and other clinical waste containers used in
hospitals must comply with these regulations,
the Health and Safety Executive
state that the act applies to
the workplace, not to private use.
Their opinion is that sharps containers used by drug
misusers at home do not have to
comply with the act.
As long as the containers in question are disposed of by
the drug misuser in larger sharps
containers which are
in compliance with the regulations, the question of compliance of the
personal container is irrelevant.
If, however, the containers are being transported as individual units
by a waste disposal
firm, health professional
or a drug worker (perhaps disposing of the unit on behalf of their
client) in their line of duty
then they should comply with the regulations.
British Standards.
British Standard BS 7320:1990 is a standard specifically
for sharps containers.
It includes specifications for the labelling and performance of sharps
containers.
Conforming containers must meet minimum performance criteria for the penetration
force of needles through
the container, and leakage after toppling or dropping from 1 metre.
It also requires that the containers be mainly yellow in colour and
possess a handle.
As most of these ``personal containers'' are black and without
handles,
they cannot comply
with this standard.
The handles are intended to reduce the risk of touching
needles which have been forced
through the container wall.
The standard is not mandatory, but SMTL and the Medical Devices Agency
always recommend that where possible, products be purchased which
comply with the relevant British Standards.
Welsh Health Legal Services (WHLS), advising Welsh Health Supplies,
state that Trusts are unlikely to
have a legal liability in relation to the containers unless it can be shown
that they collected the particular container and failed to dispose of it
appropriately.
Some manufacturers participate in the BSI kite-marking scheme for
sharps containers.
To carry a BSI kitemark, the company has to be inspected by BSI, and
have products tested independently on a regular basis.
Good Practice Guidelines
- Black containers are acceptable for home use only.
- Containers used to dispose of black sharps containers must
be UN
marked to comply with H&S legislation.
- These containers should also, preferably, comply with BS 7320.
- If a manufacturer makes claims for compliance with BS 7320,
purchasers should obtain independent data to ensure they comply.
-
A BSI kitemark means they have been independently tested and audited.
Peter Phillips
SMTL News
The Medical
Disposables and
Dressings Newsletter
Vol.~1 No.~3
January 1999
|
Published by:
The Surgical Materials
Testing Laboratory
Edited by:
Dr Stephen Thomas
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Peter Phillips
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
Contact Information
Tel: 01656-752820
Fax: 01656-752830
http://www.smtl.co.uk/
Princess of Wales Hospital
Coity Road
Bridgend
CF31 1RQ
|
©1999 by SMTL.
All rights reserved.
No permission necessary
to copy, reprint and
distribute unaltered within
the NHS as required.
This file is available
from
http://www.smtl.co.uk/
Documents/Newsletters/
|
|